Date | Price Target | Rating | Analyst |
---|---|---|---|
3/28/2024 | $13.00 → $13.50 | Buy | Needham |
3/13/2024 | Mkt Perform → Outperform | William Blair | |
2/16/2024 | $9.00 → $12.00 | Neutral → Buy | BofA Securities |
7/19/2023 | $11.00 | Buy | Craig Hallum |
8/12/2022 | $6.50 → $6.00 | Buy → Neutral | BofA Securities |
8/12/2022 | Outperform → Mkt Perform | William Blair | |
2/24/2022 | $10.50 | Overweight | JP Morgan |
2/11/2022 | $10.50 | Buy | Deutsche Bank |
6-K - Cellebrite DI Ltd. (0001854587) (Filer)
6-K - Cellebrite DI Ltd. (0001854587) (Filer)
25-NSE - Cellebrite DI Ltd. (0001854587) (Subject)
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier digital investigative solutions for the public and private sectors, announced today that Troy Richardson has joined its board of directors, effective August 13, 2024. Mr. Richardson is a seasoned technology executive with more than 30 years of experience in leading, scaling and transforming global organizations. He currently serves on the Unisys Corporation (NYSE:UIS) Board of Directors and previously served as a Director of the Board for Carestream Dental. Mr. Richardson was president of the Digital Thread group at PTC Inc. (NASDAQ:PTC) from 2021 until 2022
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced the appointment of Sigalit Shavit as Chief Information Officer (CIO) who begins her role today, August 1, 2024. Shavit joins the Company's Leadership Team, bringing with her more than 30 years of experience to Cellebrite's information technology and security team. In this newly established position that reports to CEO Yossi Carmil, Shavit will play a pivotal role in scaling the Company's ability to innovate and support customers as they strive to continue accelerating justice a
TYSONS CORNER, Va. and PETAH TIKVA, Israel, July 17, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a leader in digital investigative solutions for the public and private sectors, officially established Cellebrite Federal Solutions, further elevating the Company's ability to serve the unique needs of the U.S. federal government through its AI-driven Case-to-Closure [C2C] platform for accelerating justice. This newly established operation builds on the Company's long and rich history of serving U.S. justice, defense, intelligence and other federal civilian agencies with its world-renowned Case-to-Closure platform, assisting in critical initiatives targeting the safety and protection
Revenue of $95.7 million, 25% year-over-year increase primarily due to27% growth in subscription revenue;ARR of $345.9 million, up 26% year-over-year;Adjusted EBITDA of $21.6 million, 22.6% adjusted EBITDA margin;Company increases 2024 outlook for revenue and adjusted EBITDA, and raises midpoint for ARR TYSONS CORNER, Va. and PETAH TIKVA, Israel, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in Digital Intelligence ("DI") solutions for the public and private sectors, today announced financial results for the three and six months ending June 30, 2024. "Our outstanding second-quarter 2024 performance was highlighted by significant strategic progress and strong
TYSONS CORNER, Va. and PETAH TIKVA, Israel, July 09, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced it will report its second-quarter 2024 financial results before market open on Thursday, August 15, 2024. Later that same morning, Cellebrite will host a live conference call and webcast to review the Company's financial results for the second quarter of 2024 and discuss its 2024 outlook. Relevant details include: Date:Thursday, August 15, 2024Time:8:30 a.m. ETCall-In Number:203-518-9708Conference ID: CLBTQ224Event URL:https://investors.cellebrite.com/events/event-detai
ARR of $331.8 million, up 27% year-over-year; Q1 2024 revenue of $89.6 million, up 26% year-over-year primarily due to 29% growth in subscription revenue; Q1 2024 adjusted EBITDA of $17.6 million, 19.7% adjusted EBITDA margin TYSONS CORNER, Va. and PETAH TIKVA, Israel, May 23, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced financial results for the three months ending March 31, 2024. "Cellebrite is off to a very solid start to 2024 as we continued to grow wallet share with existing customers around the world," said Yossi Carmil, Cellebrite's CEO. "Our strong first-quarte
The Federal Bureau of Investigation (FBI) has reportedly used an unreleased technology from Israel-based digital intelligence company Cellebrite (NASDAQ:CLBT) to gain access to the phone of the individual who targeted former President Donald Trump. What Happened: After the FBI faced difficulties unlocking the phone of the shooter, identified as Thomas Matthew Crooks, they turned to Cellebrite for assistance. Despite having a license for Cellebrite’s software, the FBI’s Pittsburgh bureau was unable to bypass the passcode on Crooks’ newer Samsung model phone, which runs on Android’s operating system. Upon reaching out to Cellebrite’s team, the FBI received additional technical support a
JP Morgan analyst Brian Essex maintains Cellebrite DI (NASDAQ:CLBT) with a Overweight and raises the price target from $12 to $14.
Needham analyst Mike Cikos maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and raises the price target from $13.5 to $14.
SC 13D/A - Cellebrite DI Ltd. (0001854587) (Subject)
SC 13D/A - Cellebrite DI Ltd. (0001854587) (Subject)
SC 13G/A - Cellebrite DI Ltd. (0001854587) (Subject)
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, announced today the patent for Remote Mobile Collection, which equips corporate investigators with immediate, targeted remote data collection – saving them time and money. In today's hybrid work environment, this newly patented technology – available in Cellebrite's SaaS platforms Endpoint Mobile Now and Endpoint Inspector – delivers high value, supporting rapid data collection and offers greater convenience to the device's consenting owner, who can keep it during collection rather than retur
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Cellebrite DI Ltd. (NASDAQ:CLBT) ("Cellebrite," the "Company" or "we"), a global leader in premier Digital Investigative solutions for the public and private sectors, announced today the results of the completed redemption (the "Redemption") of its Warrants (as defined below) to purchase ordinary shares of the Company (the "Ordinary Shares"). On August 15, 2024, the Company announced that it will redeem all of its Warrants that remain outstanding at 5:00 p.m. New York City time on September 16, 2024 (the "Redemption Date") for a redemption price of $0.10 per Warrant. The Warrants include (i) the outstanding pu
Pathfinder's capabilities are now available via the cloud, giving law enforcement new deployment options to accelerate justice TYSONS CORNER, Va. and PETAH TIKVA, Israel, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, announced today Pathfinder in the Cloud with Amazon Web Services (AWS) (NASDAQ:AMZN), allowing customers to access Cellebrite's industry-leading investigative analytics solution, Pathfinder, through the secure Amazon Virtual Private Cloud (VPC). Now available for on-premises and cloud use, Pathfinder drastically reduces the hours investigators and ana
Needham reiterated coverage of Cellebrite DI with a rating of Buy and set a new price target of $13.50 from $13.00 previously
William Blair upgraded Cellebrite DI from Mkt Perform to Outperform
BofA Securities upgraded Cellebrite DI from Neutral to Buy and set a new price target of $12.00 from $9.00 previously